Company: STAA
Filing Date: 2025-12-11
Form Type: DFAN14A
Source: 0001213900-25-120792
Chunk: 2

Company: STAAR SURGICAL CO
Filing Date: 2025-12-11
Form: DFAN14A
Chunk 2
---
 AT THE STOCKHOLDER MEETING AND ADDITIONAL INFORMATION RELATING TO THE PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE. The definitive proxy statement and an accompanying GREEN Proxy Card will be furnished to some
or all of the Company’s stockholders and will be, along with other relevant documents, available at no charge on the SEC’s
website at https://www.sec.gov/.

Information about the Participants and a description
of their direct or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants
with the SEC on November 21, 2025 and is available here.

Exhibit 1

To: STAAR’s
Shareholders

From: Neal Bradsher

Subject Line: STAAR’s Board’s
Apparent Violations of its Revlon Duties

Dear Fellow STAAR Shareholder:

This morning, STAAR’s Board publicly disclosed the name of, and
cast aspersions on, a potential acquiror that did no more than show up to offer a higher price for the company’s stock during the
go-shop period. This nearly unprecedented attempt to shame a suitor was seemingly calculated to chill all interest in the company. This
outrageous move, like so much this Board has done, is wholly inconsistent with convention and the Board’s Revlon duties to shareholders.

We remain firmly AGAINST the sale to Alcon and invite you to connect
with us to discuss this vote further, if you wish.

Neal Bradsher